Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 40.20
+0.20 (0.50%)
Jan 21, 2026, 3:20 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 93.93 million as of January 21, 2026. Its market cap has decreased by -24.53% in one year.
Market Cap
93.93M
Enterprise Value
71.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40.20
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 93.93M, a decrease of -52.49%. That is a compound annual growth rate of -15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 93.93M | 1.21% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | 197.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |